HMGB1 has been reported as a DAMP for immunogenic cell death (ICD) during chemotherapy and radiotherapy, and its release from necrotic cancer cells may activate the innate immune system to promote host anticancer immunity. This evidence concerns the gene HMGB1 and cancer.